KRAS / BRAF / PIK3CA Array Enables Selection of Patients for Anti-EGFR Therapy

This video describes a single reaction multiplex PCR coupled to a biochip, which provides extensive mutation coverage of the three most important genes (KRAS, BRAF and PIK3CA) implicated in metastatic colorectal cancer therapy response.